| Morning all, Craig McGlashan here with the opening Europe Wire of the week from the London newsroom. I had a lovely trip to the cinema yesterday to see the excellent The Wild Robot with my son. It was also slightly novel as it was a 3D showing – just a few years ago, it seemed like every film was in the format, but it’s a bit of a rarity nowadays. So it was my first time wearing 3D glasses in a long, long time. Coincidentally, vision and entertainment are two of the themes in today’s Wire. First, we take a deep dive into Ardian’s plans for ophthalmology chain Vista Vision, before we look at CVC Capital Partners joining KKR in an entertainment investment. Switching to energy, we have Advent International, Arendals Fossekompani and Generation Investment Management completing their take-private for Volue and Soho Square investing in LMF Energy Services. Finishing up, Cinven-backed Synlab has sold some of its operations. Eyeing growth Ardian plans to consolidate the fragmented Italian ophthalmology market by targeting small independent clinics led by single practitioners for its Vista Vision platform, Marco Molteni, managing director, and Giacomo Brettoni, director at Ardian Expansion team, told PE Hub’s Irien Joseph. Read the premium version of the Wire to find out Ardian's growth plans for Vista, why it believes there is strong growth ahead for the ophthalmology sector and why the Italian market was particularly attractive. That’s entertainment CVC Capital Partners has invested alongside KKR in Superstruct Entertainment, a premier live entertainment group. More details in the premium version of the Wire. KKR announced its acquisition of Superstruct in June, which has now closed. Taken private Advent International, Arendals Fossekompani and Generation Investment Management have completed a voluntary tender offer for Volue. Find out more in the premium version of the Wire. Renewable energy Sticking with the energy transition, Soho Square has invested in Live Manage Facilitate, which trades as LMF Energy Services. Carving out Cinven-backed Synlab has agreed to sell its clinical diagnostics operations in Spain to bioanalytical testing company Eurofins Scientific. More details including the unit's revenue in the premium version of the Wire. OK that’s it from me today. We’re switching the schedule slightly this week due to holidays. So I’ll write to you again tomorrow, while Nina Lindholm will write to you on Thursday when I take a break. MK Flynn will bring you the US Wire later today as normal. Cheers, Craig Read the full Wire commentary on PE Hub ... | 